首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Trypan blue identifies antimetabolite treatment area in trabeculectomy
【2h】

Trypan blue identifies antimetabolite treatment area in trabeculectomy

机译:台盼蓝在小梁切除术中确定抗代谢药物的治疗区域

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: Colourless solutions of mitomycin C (MMC) and 5-fluorouracil (5-FU) are widely used during trabeculectomy to inhibit postoperative scarring. The poor visibility of these agents on the eye has several drawbacks including the inability to accurately assess the area of treatment. This study examined the utility of using trypan blue dye to colour antimetabolites used during trabeculectomy and the effect of trypan blue on antimetabolite cytotoxicity in vitro.>Methods: For in vitro experiments, MMC (0.4 mg/ml) and 5-FU (25 mg/ml) were reconstituted with or without trypan blue. A lactate dehydrogenase release assay was used to measure drug induced cell death and viable cell number 7 days after treatment. For clinical assessment, trypan blue 0.1% was added to MMC and 5-FU to final concentrations of between 0.01% and 0.05%. The mixture was applied to Tenon’s capsule and sclera via pre-wet or into dry 5×8 mm sponges (MMC and 5-FU) for 3 minutes or by direct subconjunctival injection after completion of surgery (5-FU). Twenty two consecutive patients undergoing trabeculectomy either with or without trypan blue were followed for 2 years postoperatively.>Results: The addition of 0.05% trypan blue to MMC or 5-FU did not alter MMC induced cell death or the number of viable fibroblast in vitro. In vivo, trypan blue clearly delineated the antimetabolite treatment area and facilitated control of excess antimetabolite at the wound margins as well as sponge removal. With direct subconjunctival injection, total staining area varied for a given volume with location of the needle tip. Any leakage from the injection site could be easily seen. No adverse effects attributable to trypan blue were found in 2 years of follow up.>Conclusions: Trypan blue permits delineation of antimetabolite/tissue interactions without affecting cytoxicity for the assays investigated. Trypan blue can be used to visualise antimetabolite soaked sponges, estimate treatment area, and show areas of unintended tissue contact during trabeculectomy. The addition of trypan blue to antimetabolites has potential benefits in clinical, research, and teaching aspects of ocular surgery and therapy.
机译:>目的:小梁切除术中广泛使用丝裂霉素C(MMC)和5-氟尿嘧啶(5-FU)的无色溶液来抑制术后瘢痕形成。这些药剂在眼睛上的可见性差有几个缺点,包括无法准确评估治疗区域。这项研究检查了使用锥虫蓝染料为小梁切除术中使用的抗代谢物着色的实用性以及锥虫蓝对体外抗代谢物细胞毒性的影响。>方法:对于体外实验,MMC(0.4 mg / ml)和在有或没有台盼蓝的情况下重构5-FU(25 mg / ml)。乳酸脱氢酶释放试验用于在治疗后7天测量药物诱导的细胞死亡和活细胞数。为了进行临床评估,将0.1%的锥虫蓝添加到MMC和5-FU中,使最终浓度在0.01%和0.05%之间。通过预湿或在干燥的5×8 mm海绵(MMC和5-FU)中将混合物涂在Tenon的胶囊和巩膜上3分钟,或在手术完成后通过结膜下直接注射(5-FU)。连续随访22例接受小梁切除术的伴有或不伴有锥虫蓝的患者术后2年。>结果:向MMC或5-FU中添加0.05%锥虫蓝不会改变MMC诱导的细胞死亡或活体外成纤维细胞数目。在体内,锥虫蓝清楚地划定了抗代谢物的治疗区域,并有助于控制伤口边缘多余的抗代谢物以及去除海绵。对于直接结膜下注射,在给定体积下总染色面积随针尖位置而变化。注射部位的任何泄漏都可以轻易看到。在随访的2年内未发现可归因于锥虫蓝的不良反应。>结论:锥虫蓝可以描述抗代谢物/组织之间的相互作用,而不会影响所研究的细胞毒性。锥虫蓝可用于可视化抗代谢物浸泡的海绵,估计治疗区域并显示小梁切除术中意外的组织接触区域。在抗代谢药中添加锥虫蓝在眼科手术和治疗的临床,研究和教学方面具有潜在的好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号